← Back
$WHWK All transactions

Whitehawk Therapeutics, Inc.

A

$ Value

$0

Shares

40,006

Price

$0

Filed

Jun 16

Insider

Name

Aghazadeh Behzad

Title

CIK

0001701815

Roles

Director 10% Owner Other

Transaction Details

Transaction Date

2025-06-12

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

40,006

Footnotes

Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the day immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 12, 2025. | This Form 4 is filed by Avoro Capital Advisors LLC, a Delaware limited liability company ("Avoro Capital Advisors"), Avoro Ventures LLC, a Delaware limited liability company ("Avoro Ventures") and Behzad Aghazadeh ("Dr. Aghazadeh", and together with Avoro Capital Advisors and Avoro Ventures, the "Reporting Persons"). Dr. Aghazadeh serves as the portfolio manager and controlling person of Avoro Capital Advisors and Avoro Ventures LLC. | The filing of this statement shall not be deemed an admission that any Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein.

Filing Info

Accession No.

0001415889-25-017406

Form Type

4

Issuer CIK

0001422142

Aghazadeh Behzad's History

Date Ticker Type Value
2025-06-12 WHWK A $0

Other Insiders at WHWK (90d)

Insider Bought Sold Last
Giacobello Scott M.
CHIEF FINANCIAL OFFICER
$882K 2026-04-16
BALL BRYAN
See remarks
$629K 2026-04-14
Dornan David
Chief Scientific Officer
2026-04-01
Dugan Margaret
Chief Medical Officer
2026-04-01
Lennon David James
CHIEF EXECUTIVE OFFICER
$1.0M 2026-04-09